date,title,source
Oct-17-18,Stocks Jump 2%+ on Solid Earnings,Zacks
Oct-18-18,Corbus Pharmaceuticals Presents Data on Impact of Lenabasum on Inflammation of Airway Macrophages from Cystic Fibrosis Lungs at the 2018 North American Cystic Fibrosis Conference,GlobeNewswire
Oct-22-18,Corbus Pharmaceuticals Presents Lenabasum Long-Term Open-Label Clinical Data Showing Maintenance of Favorable Safety Profile and Further Improvement in Multiple Efficacy Endpoints in Systemic Sclerosis and Dermatomyositis Phase 2 Studies,GlobeNewswire
Oct-23-18,Medical Cannabis Stocks Vs. Recreational Cannabis Stocks: Which Ones Should You Invest In?,Investopedia
Oct-23-18,"New Research Coverage Highlights MEDIFAST INC, Palo Alto Networks, Salesforce, Agile Therapeutics, Dicerna Pharmaceuticals, and Corbus Pharmaceuticals  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Nov-05-18,"Corbus Pharmaceuticals to Announce Third Quarter 2018 Operational and Financial Results on November 8, 2018",GlobeNewswire
Nov-06-18,How Much Of Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) Do Insiders Own?,Simply Wall St.
Nov-06-18,Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in November,GlobeNewswire
Nov-08-18,"Corbus Pharmaceuticals (CRBP) Reports Q3 Loss, Misses Revenue Estimates",Zacks
Nov-08-18,Corbus Pharmaceuticals: 3Q Earnings Snapshot,Associated Press
Nov-08-18,Corbus Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update,GlobeNewswire
Nov-09-18,Edited Transcript of CRBP earnings conference call or presentation 8-Nov-18 1:30pm GMT,Thomson Reuters StreetEvents
Nov-19-18,Vertex (VRTX) Gets Positive CHMP Opinion for Orkambi in Kids,Zacks
Dec-04-18,Some of December's Most Interesting Stocks,ACCESSWIRE
Dec-17-18,Corbus Pharmaceuticals Initiates DETERMINE Phase 3 Study in Dermatomyositis,GlobeNewswire
Dec-18-18,Corbus Pharmaceuticals Announces Issuance of Composition of Matter Patent Related to Lenabasum,GlobeNewswire
Dec-27-18,"Factors of Influence in 2019, Key Indicators and Opportunity within Halozyme Therapeutics, Capricor Therapeutics, Appian, Yext, Agile Therapeutics, and Corbus Pharmaceuticals  New Research Emphasizes Economic Growth",GlobeNewswire
Jan-03-19,"Corbus Pharmaceuticals Announces Strategic Collaboration with Kaken Pharmaceutical Co., Ltd. to Develop and Commercialize Lenabasum in Japan for Systemic Sclerosis and Dermatomyositis",GlobeNewswire
Jan-07-19,Implied Volatility Surging for Corbus Pharmaceuticals (CRBP) Stock Options,Zacks
Jan-24-19,Corbus Pharmaceuticals Announces Proposed Public Offering of Common Stock,GlobeNewswire
Jan-25-19,Corbus Pharmaceuticals Announces Pricing of Public Offering of Common Stock,GlobeNewswire
Jan-29-19,Jim Cramer Shares His Predictions For The Cannabis Industry,Benzinga
Jan-30-19,Corbus Pharmaceuticals Announces Closing of $40 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares,GlobeNewswire
Jan-31-19,Biotech Stocks on the Rise,ACCESSWIRE
Feb-05-19,Top Marijuana Stocks on the NASDAQ,Investopedia
Feb-05-19,"Market Trends Toward New Normal in Brixmor Property Group, Navigant Consulting, Allete, Dun & Bradstreet, Corbus Pharmaceuticals, and International Seaways  Emerging Consolidated Expectations, Analyst Ratings",GlobeNewswire
Feb-07-19,"Should Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Be Your Next Stock Pick?",Simply Wall St.
Feb-11-19,Corbus Pharmaceuticals (CRBP) Stock Sinks As Market Gains: What You Should Know,Zacks
Feb-12-19,Tuesday's Rally Was Driven Mostly by Technical Conditions,TheStreet.com
Feb-12-19,It's a Stock Picker's Delight Right Now,TheStreet.com
Feb-19-19,Is the Options Market Predicting a Spike in Corbus Pharmaceuticals (CRBP) Stock?,Zacks
